查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942851

2026年全球纖維蛋白膠市場報告

Fibrin Sealants Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，纖維蛋白膠市場經歷了顯著成長，預計到2025年將達到11.7億美元，到2026年將達到12.7億美元，複合年成長率（CAGR）為8.4%。過去幾年成長要素包括：重組和合成密封劑供應有限、對自體和牛密封劑的依賴、外科手術數量的增加、止血意識的提高以及纖維蛋白膠在普通外科手術中的應用日益廣泛。

預計未來幾年纖維蛋白膠市場將維持強勁成長，2030年市場規模將達到17.3億美元，複合年成長率（CAGR）為8.0%。預測期內的成長要素包括重組纖維蛋白生產技術的進步、微創和機器人手術的興起、心血管和整形外科手術需求的成長、監管核准和品質認證的增加，以及生物可吸收和多功能密封劑的研發。預測期內的主要趨勢包括微創手術中纖維蛋白膠的日益普及、重組和合成密封劑的廣泛應用、整形外科和心血管外科手術的擴展、對血液保護和止血的日益重視，以及對生物可吸收和貼片式密封劑的偏好不斷增強。

預計未來美容手術數量的不斷成長將進一步推動纖維蛋白膠市場的擴張。美容手術是一種主要旨在改善或改變外觀的醫療程序。美容手術數量的增加與社會對美的日益重視、外科技術的進步以及微創手術的日益普及密切相關。纖維蛋白膠透過加速創傷治療、減少出血、降低疤痕形成以及改善整體手術效果和恢復情況來輔助美容手術。例如，根據美國整形外科醫師協會旗下子公司 CosmetAssure 的數據，截至 2023 年 9 月，抽脂術仍然是 2023 年最常進行的美容手術，共進行了 347,782 例，比 2022 年成長了 7%。同時，腹部手術數量增加了 5%，達到 170,110 例。因此，美容手術數量的成長增強了纖維蛋白膠市場的成長前景。

纖維蛋白膠市場的主要企業正致力於開發創新解決方案，例如纖維蛋白膠，以改善止血效果、減少手術併發症、加速創傷治療並促進患者復原。纖維蛋白膠是一種源自血液成分的生物黏合劑，能夠模擬自然凝血的最後階段。例如，2024年10月，西班牙生物製藥公司Grifols SA的纖維蛋白膠已獲得FDA核准，用於治療兒童患者的手術出血。本產品有助於精準止血，減少術後併發症，並可用於多種外科手術。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球纖維蛋白膠市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 微創手術中纖維蛋白膠的應用日益增多
    • 重組和合成密封劑的使用日益增多
    • 擴大整形外科和心血管外科手術
    • 更加重視血液保護和止血
    • 人們對生物可吸收密封劑和補片密封劑的偏好日益成長

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 整形外科診所
  • 心血管外科中心
  • 其他專科手術中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球纖維蛋白膠市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球纖維蛋白膠市場規模、對比及成長率分析
  • 全球纖維蛋白膠市場表現：規模與成長，2020-2025年
  • 全球纖維蛋白膠市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 液體、貼片、粉劑
  • 透過技術
  • 自體捐贈、病毒去活化、重組生產及其他技術
  • 透過使用
  • 一般外科、心血管外科、傷口處理、整形外科手術、泌尿系統手術、眼科手術、移植手術等應用
  • 最終用戶
  • 醫院、門診手術中心和其他最終用戶
  • 按類型細分：液體
  • 牛源性液體密封劑、人類液體密封劑、合成液體密封劑、重組纖維蛋白膠
  • 按類型細分：補丁
  • 牛纖維蛋白貼片、人類纖維蛋白貼片、合成纖維蛋白貼片、生物可吸收纖維蛋白貼片
  • 按類型細分：粉末
  • 牛纖維蛋白粉、人類纖維蛋白粉、合成纖維蛋白粉、重組纖維蛋白粉

第10章 區域與國家分析

  • 全球纖維蛋白膠市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球纖維蛋白膠市場：按國家、性能和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 纖維蛋白膠市場：競爭格局與市場佔有率，2024 年
  • 纖維蛋白膠市場：公司估值矩陣
  • 纖維蛋白膠市場：公司概況
    • Johnson & Johnson
    • Takeda Pharmaceutical Company Limited
    • Asahi Kasei Medical Co. Ltd.
    • Baxter International Inc.
    • CSL Behring

第37章：其他領先和創新企業

  • Grifols SA, Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年纖維蛋白膠市場：提供新機會的國家
  • 2030年纖維蛋白膠市場：新興細分市場機會
  • 2030年纖維蛋白膠市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME5MFSEA03_G26Q1

Fibrin sealants, also called fibrin glues or tissue adhesives, are medical products used to support blood clotting and promote tissue healing. Made from fibrinogen and thrombin-proteins involved in natural clot formation-they are commonly used in surgery to control bleeding in delicate areas where stitches or cauterization may not be sufficient.

The primary types in the fibrin sealants market include liquid, patch, and powder formulations. Liquid fibrin sealants contain fibrinogen and thrombin, which combine to form a fibrin clot when applied. These products are used during surgical procedures to control bleeding and enhance tissue bonding and can be administered through methods such as dripping or spraying for accurate placement. The technologies include autologous donation, viral inactivation, recombinant production, and others. The applications span general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, transplant surgery, and others, and the end users include hospitals, ambulatory surgical centers, and other healthcare facilities.

Tariffs have influenced the fibrin sealants market by increasing the cost of imported raw materials and advanced production equipment, including recombinant protein production systems. Segments such as recombinant and synthetic sealants are particularly impacted, with Asia-Pacific regions like China and India facing higher import duties. This has led to increased production costs and potential delays in supply. On the positive side, tariffs encourage local production, investment in domestic manufacturing facilities, and innovation in cost-effective sealant solutions.

The fibrin sealants market research report is one of a series of new reports from The Business Research Company that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fibrin sealants market size has grown strongly in recent years. It will grow from $1.17 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to limited availability of recombinant and synthetic sealants, reliance on autologous and bovine-derived sealants, increasing surgical procedures, rising awareness about hemostasis, adoption of fibrin sealants in general surgeries.

The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to advancements in recombinant fibrin production, growth in minimally invasive and robotic surgeries, increasing demand in cardiovascular and orthopedic procedures, rising regulatory approvals and quality certifications, development of bioabsorbable and multifunctional sealants. Major trends in the forecast period include rising adoption of fibrin sealants in minimally invasive surgeries, increasing use of recombinant and synthetic sealants, expansion of orthopedic and cardiovascular surgeries, growing focus on blood conservation and hemostasis, rising preference for bioabsorbable and patch-based sealants.

The increasing number of cosmetic surgeries is increasingly supporting the expansion of the fibrin sealants market going forward. Cosmetic surgeries are medical procedures primarily performed to enhance or modify physical appearance. The growing volume of cosmetic surgeries is linked to societal emphasis on aesthetics, advancements in surgical techniques, and increased availability of minimally invasive procedures. Fibrin sealants assist cosmetic surgeries by promoting faster wound healing, minimizing bleeding, reducing scarring, and improving overall surgical outcomes and recovery. For example, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons organization, liposuction remained the most frequently performed cosmetic surgery in 2023 with 347,782 procedures, reflecting a 7% increase from 2022, while tummy tuck procedures rose by 5% to 170,110 cases. Consequently, the rising number of cosmetic surgeries is strengthening growth prospects for the fibrin sealants market.

Leading companies operating in the fibrin sealants market are focusing on developing innovative solutions, such as fibrin sealants, to improve hemostasis, reduce surgical complications, enhance wound healing, and support patient recovery. Fibrin sealants are biological adhesives derived from blood components that replicate the final steps of natural clot formation. For example, in October 2024, Grifols S.A., a Spain-based biopharmaceutical company, received FDA approval for its fibrin sealant for treating surgical bleeding in pediatric patients. The product supports precise hemostasis, reduces postoperative complications, and can be used across a variety of surgical settings.

In July 2024, Corza Medical, a US-based manufacturer of advanced surgical technologies, acquired Takeda's TachoSil manufacturing operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to improve service levels and enhance global customer support. Takeda is a Japan-based pharmaceutical company involved in the development and production of fibrin sealants.

Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc

North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibrin sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fibrin Sealants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses fibrin sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fibrin sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fibrin sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Liquid; Patch; Powder
  • 2) By Technology: Autologous Donation; Viral Inactivation; Recombinant Production; Other Technologies
  • 3) By Application: General Surgery; Cardiovascular Surgery; Wound Management; Orthopedic Surgery; Urological Surgeries; Ophthalmic Surgeries; Transplant Surgery; Other Applications
  • 4) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Liquid: Bovine-Derived Liquid Sealants; Human-Derived Liquid Sealants; Synthetic Liquid Sealants; Recombinant Fibrin Sealants
  • 2) By Patch: Bovine-Derived Fibrin Patches; Human-Derived Fibrin Patches; Synthetic Fibrin Patches; Bioabsorbable Fibrin Patches
  • 3) By Powder: Bovine-Derived Fibrin Powder; Human-Derived Fibrin Powder; Synthetic Fibrin Powder; Recombinant Fibrin Powder
  • Companies Mentioned: Johnson & Johnson; Takeda Pharmaceutical Company Limited; Asahi Kasei Medical Co. Ltd.; Baxter International Inc.; CSL Behring; Grifols S.A.; Sigma-Aldrich; Nordson Corporation; Integra LifeSciences Corporation; Shanghai RAAS Blood Products Co. Ltd.; Mallinckrodt Pharmaceuticals; Biotest AG; LFB Group; Hualan Biological Engineering Inc.; Corza Medical; Aesculap Inc.; Ethicon Inc.; CryoLife Inc.; VIVEX Biologics Inc.; MediWound Ltd.; Cohesion Technologies Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Fibrin Sealants Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Fibrin Sealants Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Fibrin Sealants Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Fibrin Sealants Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Fibrin Sealants In Minimally Invasive Surgeries
    • 4.2.2 Increasing Use Of Recombinant And Synthetic Sealants
    • 4.2.3 Expansion Of Orthopedic And Cardiovascular Surgeries
    • 4.2.4 Growing Focus On Blood Conservation And Hemostasis
    • 4.2.5 Rising Preference For Bioabsorbable And Patch-Based Sealants

5. Fibrin Sealants Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Orthopedic Clinics
  • 5.4 Cardiovascular Surgery Centers
  • 5.5 Other Specialty Surgery Centers

6. Fibrin Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Fibrin Sealants Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Fibrin Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Fibrin Sealants Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Fibrin Sealants Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Fibrin Sealants Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Fibrin Sealants Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Fibrin Sealants Market Segmentation

  • 9.1. Global Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liquid, Patch, Powder
  • 9.2. Global Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Autologous Donation, Viral Inactivation, Recombinant Production, Other Technologies
  • 9.3. Global Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, Urological Surgeries, Ophthalmic Surgeries, Transplant Surgery, Other Applications
  • 9.4. Global Fibrin Sealants Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Other End-Users
  • 9.5. Global Fibrin Sealants Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bovine-Derived Liquid Sealants, Human-Derived Liquid Sealants, Synthetic Liquid Sealants, Recombinant Fibrin Sealants
  • 9.6. Global Fibrin Sealants Market, Sub-Segmentation Of Patch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bovine-Derived Fibrin Patches, Human-Derived Fibrin Patches, Synthetic Fibrin Patches, Bioabsorbable Fibrin Patches
  • 9.7. Global Fibrin Sealants Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bovine-Derived Fibrin Powder, Human-Derived Fibrin Powder, Synthetic Fibrin Powder, Recombinant Fibrin Powder

10. Fibrin Sealants Market Regional And Country Analysis

  • 10.1. Global Fibrin Sealants Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Fibrin Sealants Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Fibrin Sealants Market

  • 11.1. Asia-Pacific Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Fibrin Sealants Market

  • 12.1. China Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Fibrin Sealants Market

  • 13.1. India Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Fibrin Sealants Market

  • 14.1. Japan Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Fibrin Sealants Market

  • 15.1. Australia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Fibrin Sealants Market

  • 16.1. Indonesia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Fibrin Sealants Market

  • 17.1. South Korea Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Fibrin Sealants Market

  • 18.1. Taiwan Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Fibrin Sealants Market

  • 19.1. South East Asia Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Fibrin Sealants Market

  • 20.1. Western Europe Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Fibrin Sealants Market

  • 21.1. UK Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Fibrin Sealants Market

  • 22.1. Germany Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Fibrin Sealants Market

  • 23.1. France Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Fibrin Sealants Market

  • 24.1. Italy Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Fibrin Sealants Market

  • 25.1. Spain Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Fibrin Sealants Market

  • 26.1. Eastern Europe Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Fibrin Sealants Market

  • 27.1. Russia Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Fibrin Sealants Market

  • 28.1. North America Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Fibrin Sealants Market

  • 29.1. USA Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Fibrin Sealants Market

  • 30.1. Canada Fibrin Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Fibrin Sealants Market

  • 31.1. South America Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Fibrin Sealants Market

  • 32.1. Brazil Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Fibrin Sealants Market

  • 33.1. Middle East Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Fibrin Sealants Market

  • 34.1. Africa Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Fibrin Sealants Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Fibrin Sealants Market Regulatory and Investment Landscape

36. Fibrin Sealants Market Competitive Landscape And Company Profiles

  • 36.1. Fibrin Sealants Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Fibrin Sealants Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Fibrin Sealants Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Asahi Kasei Medical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

37. Fibrin Sealants Market Other Major And Innovative Companies

  • Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd.

38. Global Fibrin Sealants Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Fibrin Sealants Market

40. Fibrin Sealants Market High Potential Countries, Segments and Strategies

  • 40.1 Fibrin Sealants Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Fibrin Sealants Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Fibrin Sealants Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer